Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001209191-23-023942

Chief Executive Officer sold 10,000 shares at $96.13 ($961,300)

  • Chief Executive Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BIENAIME JEAN JACQUES · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $67.81 $678,100 435,896 D
2023-04-06 Sale : show line 2 in the form 10b5-1 −10,000 $96.13 $961,300 425,896 D
Open-market sales · 10,000 sh · avg $96.13 · $961,300

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-06 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy Common Stock) −10,000 139,130 D
Loading xslF345X04/doc4.xml…